IL139263A0 - Phenylsulfonamide phenylethylamines useful as dopamine receptors - Google Patents

Phenylsulfonamide phenylethylamines useful as dopamine receptors

Info

Publication number
IL139263A0
IL139263A0 IL13926399A IL13926399A IL139263A0 IL 139263 A0 IL139263 A0 IL 139263A0 IL 13926399 A IL13926399 A IL 13926399A IL 13926399 A IL13926399 A IL 13926399A IL 139263 A0 IL139263 A0 IL 139263A0
Authority
IL
Israel
Prior art keywords
phenylethylamines
phenylsulfonamide
useful
dopamine receptors
alkyl
Prior art date
Application number
IL13926399A
Other languages
English (en)
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of IL139263A0 publication Critical patent/IL139263A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13926399A 1998-05-14 1999-05-07 Phenylsulfonamide phenylethylamines useful as dopamine receptors IL139263A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8549398P 1998-05-14 1998-05-14
PCT/US1999/007023 WO1999058499A1 (en) 1998-05-14 1999-05-07 Phenylsulfonamide-phenylethylamines useful as dopamine receptors

Publications (1)

Publication Number Publication Date
IL139263A0 true IL139263A0 (en) 2001-11-25

Family

ID=22191975

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13926399A IL139263A0 (en) 1998-05-14 1999-05-07 Phenylsulfonamide phenylethylamines useful as dopamine receptors

Country Status (25)

Country Link
US (1) US6103766A (zh)
EP (1) EP1077935B1 (zh)
JP (1) JP2002514623A (zh)
KR (1) KR20010043546A (zh)
CN (1) CN1152857C (zh)
AT (1) ATE253045T1 (zh)
AU (1) AU752543B2 (zh)
BR (1) BR9910405A (zh)
CA (1) CA2327345A1 (zh)
DE (1) DE69912419T2 (zh)
DK (1) DK1077935T3 (zh)
EA (1) EA002918B1 (zh)
ES (1) ES2211078T3 (zh)
HK (1) HK1036049A1 (zh)
HU (1) HUP0101746A3 (zh)
IL (1) IL139263A0 (zh)
NO (1) NO20005732L (zh)
NZ (1) NZ508152A (zh)
PL (1) PL343891A1 (zh)
PT (1) PT1077935E (zh)
SK (1) SK16242000A3 (zh)
TR (1) TR200003325T2 (zh)
TW (1) TW450954B (zh)
WO (1) WO1999058499A1 (zh)
ZA (1) ZA200005921B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT971878E (pt) * 1997-02-27 2008-07-08 Takeda Pharmaceutical Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta
JP2004535390A (ja) * 2001-05-07 2004-11-25 スミスクライン・ビーチャム・コーポレイション スルホンアミド
US20050043536A1 (en) * 2001-05-07 2005-02-24 Dashyant Dhanak Sulfonamides
WO2006040179A1 (en) * 2004-10-14 2006-04-20 Abbott Gmbh & Co. Kg Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
WO2006040182A1 (en) 2004-10-14 2006-04-20 Abbott Gmbh & Co. Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
WO2006040176A1 (en) 2004-10-14 2006-04-20 Abbott Gmbh & Co. Kg Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EP2013179B1 (en) 2006-04-14 2011-01-19 Abbott GmbH & Co. KG Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
ES2360254T3 (es) * 2006-04-14 2011-06-02 ABBOTT GMBH & CO. KG Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3.
US8642642B2 (en) 2006-04-19 2014-02-04 Abbott Laboratories Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
TW200808762A (en) 2006-04-19 2008-02-16 Abbott Gmbh & Co Kg Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US5451677A (en) * 1993-02-09 1995-09-19 Merck & Co., Inc. Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity
GB9402197D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
AU4368996A (en) * 1994-11-23 1996-06-17 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
ATE232850T1 (de) * 1996-05-11 2003-03-15 Smithkline Beecham Plc Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
JPH1180156A (ja) * 1997-09-04 1999-03-26 Hokuriku Seiyaku Co Ltd １−（置換アリール）アルキル−１ｈ−イミダゾピリジン−４−アミン誘導体

Also Published As

Publication number Publication date
DE69912419T2 (de) 2004-07-22
US6103766A (en) 2000-08-15
AU3741899A (en) 1999-11-29
BR9910405A (pt) 2001-01-09
NO20005732D0 (no) 2000-11-13
JP2002514623A (ja) 2002-05-21
CN1297431A (zh) 2001-05-30
CA2327345A1 (en) 1999-11-18
PT1077935E (pt) 2004-03-31
NO20005732L (no) 2000-11-13
EP1077935A1 (en) 2001-02-28
SK16242000A3 (sk) 2001-06-11
KR20010043546A (ko) 2001-05-25
HUP0101746A2 (hu) 2002-03-28
HK1036049A1 (en) 2001-12-21
AU752543B2 (en) 2002-09-19
CN1152857C (zh) 2004-06-09
HUP0101746A3 (en) 2002-10-28
DK1077935T3 (da) 2004-02-16
EP1077935B1 (en) 2003-10-29
ZA200005921B (en) 2001-11-14
DE69912419D1 (de) 2003-12-04
PL343891A1 (en) 2001-09-10
TW450954B (en) 2001-08-21
ES2211078T3 (es) 2004-07-01
ATE253045T1 (de) 2003-11-15
TR200003325T2 (tr) 2001-04-20
NZ508152A (en) 2003-03-28
EA002918B1 (ru) 2002-10-31
WO1999058499A1 (en) 1999-11-18
EA200001184A1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
IL139263A0 (en) Phenylsulfonamide phenylethylamines useful as dopamine receptors
DK0923542T3 (da) Arylsubstituerede cycliske aminer som selektive dopamin-D3-ligander
ES2031513T3 (es) Quinazolindionas y piridopirimidinadionas.
HK1008897A1 (en) 2-Aminoindans as selective dopamine d3 ligands.
EA200100671A1 (ru) ПРОИЗВОДНЫЕ 2,3,4,4a-ТЕТРАГИДРО-1H-ПИРАЗИНО [1,2a]ХИНОКСАЛИН-5(6H)-ОНА, ЯВЛЯЮЩИЕСЯ АГОНИСТАМИ 5HT2C
NZ299859A (en) Oxazolidine and morpholine derivatives; medicaments for treatment of central nervous system diseases
PT1204654E (pt) Benzofurilpiperazinas agonistas do receptor 5-ht2c da serotonina
FI943247A (fi) Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina
BR9908321A (pt) Composto
DE60014339D1 (de) Aryl- und heteroaryl-kondensierte aminoalkyl-imidazol-derivate: selektive modulatoren der gabaa-rezeptoren
ES2182509T3 (es) Derivados de n-ariloxietilamina para el tratamiento de la depresion.
PE20040788A1 (es) Derivados de indol con afinidad al receptor de androgeno
AP2000002009A0 (en) Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity.
MX9703712A (es) Derivados de 6-metoxi-1h-benzotriazol-5-carboxamida, sus procesos de produccion y las composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees